Alexandria Hammond
Stock Analyst at Wolfe Research
(0.18)
# 4,793
Out of 5,189 analysts
51
Total ratings
48.5%
Success rate
-24.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alexandria Hammond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Reiterated: Buy | $135 → $180 | $133.72 | +34.61% | 4 | Aug 25, 2026 | |
| MRNA Moderna | Upgraded: Hold | n/a | $195.00 | - | 7 | Aug 25, 2026 | |
| ABBV AbbVie | Upgraded: Buy | $300 | $286.20 | +4.82% | 3 | Aug 13, 2026 | |
| BIIB Biogen | Upgraded: Buy | $300 | $249.59 | +20.20% | 2 | Aug 13, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,325 → $1,350 | $1,347.11 | +0.21% | 6 | May 21, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $1,150 → $860 | $920.69 | -6.59% | 2 | May 18, 2026 | |
| PFE Pfizer | Reiterated: Sell | $25 → $26 | $27.40 | -5.11% | 5 | May 13, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $200 → $225 | $270.47 | n/a | 7 | Oct 15, 2025 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $95 | $60.41 | n/a | 3 | Jul 15, 2025 | |
| GILD Gilead Sciences | Initiated Coverage: Buy | $110 → $109 | $166.43 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $435.64 | n/a | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $58.80 | n/a | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 | $379.10 | n/a | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $550 | $515.02 | n/a | 2 | Aug 2, 2024 |
Merck & Co.
Aug 25, 2026
Reiterated: Buy
Price Target: $135 → $180
Current: $133.72
Upside: +34.61%
Moderna
Aug 25, 2026
Upgraded: Hold
Price Target: n/a
Current: $195.00
Upside: -
AbbVie
Aug 13, 2026
Upgraded: Buy
Price Target: $300
Current: $286.20
Upside: +4.82%
Biogen
Aug 13, 2026
Upgraded: Buy
Price Target: $300
Current: $249.59
Upside: +20.20%
Eli Lilly and Company
May 21, 2026
Reiterated: Buy
Price Target: $1,325 → $1,350
Current: $1,347.11
Upside: +0.21%
Regeneron Pharmaceuticals
May 18, 2026
Reiterated: Buy
Price Target: $1,150 → $860
Current: $920.69
Upside: -6.59%
Pfizer
May 13, 2026
Reiterated: Sell
Price Target: $25 → $26
Current: $27.40
Upside: -5.11%
Johnson & Johnson
Oct 15, 2025
Reiterated: Buy
Price Target: $200 → $225
Current: $270.47
Upside: n/a
BioMarin Pharmaceutical
Jul 15, 2025
Reiterated: Buy
Price Target: $95
Current: $60.41
Upside: n/a
Gilead Sciences
Dec 10, 2024
Initiated Coverage: Buy
Price Target: $110 → $109
Current: $166.43
Upside: n/a
Nov 14, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $435.64
Upside: n/a
Nov 14, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $58.80
Upside: n/a
Aug 7, 2024
Reiterated: Sell
Price Target: $150
Current: $379.10
Upside: n/a
Aug 2, 2024
Reiterated: Buy
Price Target: $550
Current: $515.02
Upside: n/a